Reicker Pfau Represents LungLife AI in its AIM Debut

Reicker Pfau represented LungLife AI (LLAI) in its admission to the AIM market of The London Stock Exchange. LungLife was admitted to AIM on July 8, 2021 and raised £17 million at a price at 176p, valuing the company at £45 million upon admission.

The Reicker Pfau team was led by partner Russell Terry.

A full article from Vox Markets can be found here.

Share this post

Share on linkedin
Share on twitter
Share on facebook
Share on print
Share on email